{
    "clinical_study": {
        "@rank": "26577", 
        "arm_group": [
            {
                "arm_group_label": "Cryoprobe biopsy", 
                "arm_group_type": "Active Comparator", 
                "description": "All patients enrolled will undergo standard forceps biopsies followed by cryoprobe biopsies and results will be compared"
            }, 
            {
                "arm_group_label": "Forceps Biopsy", 
                "arm_group_type": "Active Comparator", 
                "description": "All patients enrolled will undergo standard forceps biopsies followed by cryoprobe biopsies and results will be compared"
            }
        ], 
        "brief_summary": {
            "textblock": "Lung transplant recipients undergo bronchoscopy with biopsies for clinical indications and\n      for surveillance in the diagnosis of acute rejection using standard transbronchial forceps.\n      It is recognized that standard forceps biopsies underestimate the presence or degree of\n      airway rejection due to crush artifact and sample size. Transbronchial cryobiopies have been\n      shown in the literature to provide larger samples without crush artifact in a safe fashion\n      in lung cancer patients. The aim of this study is to determine if transbronchial cryobiopsy\n      is superior to standard transbronchial forceps biopsies in regards to sample size,\n      architecture and the diagnosis of early rejection in lung transplant recipients which if\n      discovered earlier may improve survival."
        }, 
        "brief_title": "Cryoprobe Transbronchial Lung Biopsy in Lung Transplant Patients", 
        "condition": "Lung Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Individuals referred for either clinically indicated or surveillance flexible\n             bronchoscopy will be included in the study population\n\n          -  Age greater than 18 years and having undergone bilateral orthotopic lung\n             transplantation\n\n        Exclusion Criteria:\n\n          -  Coagulopathy: plts < 50K, INR > 1.5\n\n          -  FEV1 < 0.8\n\n          -  Diffuse bullous disease\n\n          -  Hemodynamic instability\n\n          -  Severe hypoxemia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "91", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694615", 
            "org_study_id": "NA_00052081"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cryoprobe biopsy", 
                "description": "none", 
                "intervention_name": "Cryoprobe biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Forceps Biopsy", 
                "intervention_name": "Forceps Biopsy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung Transplantation", 
            "Acute Rejection"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "link": {
            "url": "http://www.hopkinsmedicine.org/ip"
        }, 
        "location": {
            "contact": {
                "email": "lyarmus@jhmi.edu", 
                "last_name": "Lonny Yarmus"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21287"
                }, 
                "name": "Johns Hopkins Hospital"
            }, 
            "investigator": {
                "last_name": "Lonny Yarmus", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Controlled Study of Transbronchial Cryoprobe Versus Forceps Biopsy for Acute Rejection in Lung Transplantation", 
        "overall_contact": {
            "email": "lyarmus@jhmi.edu", 
            "last_name": "Lonny Yarmus"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Lonny Yarmus", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Direct measurements of pathologic specimens from the forceps and cryoprobe will be compared. In addition, amount of crush artifact will alse be directly measured and compared utilizing pathology software which measures area of viable tissue.", 
            "measure": "Differences in size of biopsy specimen and architectural preservation of the airways/alveoli (ie degree of crush artifact)", 
            "safety_issue": "No", 
            "time_frame": "From date of study enrollment until the patient is 2 years post lung transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694615"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Lonny Yarmus", 
            "investigator_title": "Assistant Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Each specimen will be independently reviewed by a lung transplant pathology physician to determine the presence or absence of rejection and results compared. All data will be available to the transplant team in the event any rejection is found, it will be acted upon immediately as per the transplant teams protocol.", 
            "measure": "Diagnostic yield (ie presence of ACR, chronic rejection, lymphocytic bronchiolitis and infection)", 
            "safety_issue": "No", 
            "time_frame": "From date of study enrollment until the patient is 2 years post lung transplant"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}